CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

May 3, 2022 · earnings

ESPR earnings: a positive outcome, +14.0%

On May 3, 2022, Esperion Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +14.0% in the window around the event. It had already run +14.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$5.73
1d before
$6.53
Event day
$6.38
1d after
$5.51
5d after

Pre-catalyst setup

+14.5%
30-day run-up
7527%
30-day volatility
0.9×
volume spike